Richard Scott Struthers - President & CEO, Director at Crinetics Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Issuer Symbol
CRNX on Nasdaq
All Insider Reports
All Insider Reports

Richard Scott Struthers - trading volume in the past year for Crinetics Pharmaceuticals, Inc.

Holdings reported by Richard Scott Struthers for Crinetics Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 661,205 $36,822,506 $55.69 23 Feb 2026 By Family Trust 1
Common Stock 426,759 $23,766,208 $55.69 23 Feb 2026 Direct
Common Stock 110,000 $6,125,900 $55.69 23 Feb 2026 By Family Trust 3
Common Stock 106,000 $5,903,140 $55.69 23 Feb 2026 By Family Trust 2
Common Stock 100,000 $5,569,000 $55.69 23 Feb 2026 By Family Trust 4
Common Stock 1,000 $55,690 $55.69 23 Feb 2026 By Spouse
Stock Option (Right to Buy) 228,000 23 Feb 2026 Direct Common Stock

Transactions reported by Richard Scott Struthers for Crinetics Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.